 |
Oct 23, 2009: Medgenics Signs development agreement with major international pharma company |
|
Sep 3 2009: CEO to Present at Rodman & Renshaw Conference |
|
Aug 27 2009: Patient Nearing Unprecedented 11 months of Anemia Relief |
|
June 11 2009: Medgenics CEO to Present EPODURE AT Biomed Conference |
|
May 22 2009: Preliminary Results: The Annual Report and Accounts of the Company |
|
May 11 2009: Medgenics requests Stockholder Action in connection with fund raising through the proposed issue of convertible debentures |
|
Mar 27 2009: Encouraging results of the Company’s ongoing EPODURE Biopump Phase I/II Clinical Trial |
|
Feb 27 2009: Crystal Research Issues Quarterly Update |
|
Feb 3 2009: Medgenics Announces Positive Data from Phase I/II Clinical
Trial of Epodure Treatment of Anemia in Chronic Kidney Disease |
|
Nov 3 2008: Medgenics Announces Preliminary Data: The landmark Phase I/II clinical trial of Medgenics’ EPODURE Biopump, for providing sustained |
|
July 30, 2008: Medgenics Granted Approval: to Commence Its Landmark Phase I/II Clinical Study of EPODURE to treat Anemia |
|
April 14, 2008: Research Update: Medgenics on target to start Phase I/II clinical trials with EPODURE protein therapy for anaemia mid-2008 as planned
|
|
Mar 18, 2008: Medgenics consolidates corporate and R&D
operations into new office facility
|
|
Feb 1, 2008: Lord Steinberg Appointment, Medgenics (AIM: MEDG), the US incorporated biopharmaceutical company that was admitted to AIM in December 2007, is pleased to announce...
|
|
Dec 4, 2007: ADMISSION TO TRADING Karmiel, Israel and London, UK – 4 December, 2007 – Medgenics (AIM: MEDG), the US incorporated holding company of a biopharmaceutical group, is pleased to announce...
|
|
Nov 29, 2007: Medgenics raises £3.28 Million in initial public offering in conjunction with forthcoming listing on AIM Karmiel, Israel and London, UK - 29 November, 2007 - Medgenics, Inc., a US biopharmaceutical company with key operations in Israel...
|
|
Nov 1, 2006: Medgenics To Present At Rodman & Renshaw 8th Annual Healthcare Conference
CEO to Share Clinical Proof of Principle and Development Strategy
|
